In the US Preventive Services Task Force Recommendation Statement titled “Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement,” published in the August 24, 2021, issue of JAMA,1 a diagnostic testing standard was unclear. In the “Practice Considerations” section, the last sentence of the “Screening Tests” subsection should have read “The diagnosis of type 2 diabetes should be confirmed with repeat testing.” This article was corrected online.
1.Davidson
KW, Barry
MJ, Mangione
CM,
et al; US Preventive Services Task Force. Screening for prediabetes and type 2 diabetes: US Preventive Services Task Force recommendation statement.
JAMA. 2021;326(8):736-743. doi:
10.1001/jama.2021.12531PubMedGoogle Scholar